Benkerrou, M <br/><br/>
Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.  [electronic resource] 

 -  Blood  Nov 1998 
 - 3137-47 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Neoplasm--immunology<br/>Antibody Specificity<br/>Antigens, CD--immunology<br/>Antigens, Neoplasm--immunology<br/>B-Lymphocytes--immunology<br/>CD24 Antigen<br/>Child<br/>Child, Preschool<br/>Clone Cells--immunology<br/>Cohort Studies<br/>Epstein-Barr Virus Infections--immunology<br/>Female<br/>Humans<br/>Immunization, Passive<br/>Immunosuppression Therapy--adverse effects<br/>Infant<br/>Lymphoproliferative Disorders--etiology<br/>Male<br/>Membrane Glycoproteins<br/>Mice<br/>Middle Aged<br/>Prognosis<br/>Receptors, Complement 3d--immunology<br/>Remission Induction<br/>Risk Factors<br/>Survival Analysis<br/>Transplantation--adverse effects<br/>Treatment Outcome